MACH-NC v3.

This second update of the massive meta-analysis of chemoradiation trials for head and neck cancer confirms the superiority of concurrent chemotherapy over induction and adjuvant approaches. Survival and locoregional control were better with concurrent than sequential chemoradiation. The survival improvement was 6.5% at 5 years and 3.6% at 10 years. | Lacas Radiother Oncol 2021

Comments

Popular Posts